Multipotent stem cell research has come into the mainstream, as regenerative medicine exits its infancy and begins to take hold in major healthcare markets worldwide. The possibilities inherent in multipotent stem cells – those capable of turning into a wide variety of different bodily cells – make it one of the most exciting developments today. [Read more…]
BBG Advanced Therapies collects first cell donation on one-of-a-kind bus
New vehicle to help enable lifesaving new advanced therapies
The world’s only mobile leukapheresis center recorded its first donation on Monday, Oct. 20, marking the beginning of a new era for global healthcare.
The BBG Advanced Therapies mobile leukapheresis center, the first of its kind in the world, can help improve access to lifesaving treatments across an area of almost 70,000 square miles currently underserved by next-generation advanced therapies. [Read more…]
TEDCO Announces Panel to Discuss the Road to Clinical Trials at 2025 Entrepreneur Expo
COLUMBIA, Md., October 9, 2025 — TEDCO, Maryland’s economic engine for technology companies, announces the panel “The Road to Clinical Trials” to take place at the upcoming 2025 Entrepreneur Expo at The Hotel at the University of Maryland on October 21, 2025.
“The transition from discovery to clinical application represents one of the most complex and pivotal phases of medical research” said Ben Antebi, associate director, Maryland Stem Cell Research Fund (MSCRF). “Navigating this critical pathway properly has a direct impact on shaping the fate of a technology.” [Read more…]
Xintela’s stem cell product XSTEM shows safety and sustained positive efficacy results two years after treatment in knee osteoarthritis clinical study
The final analysis including the 24-month evaluation of Xintela’s (XINT) clinical study on XSTEM for knee osteoarthritis has now been completed. The results show continued safety, reduction of knee pain, improved joint function, and improvements in bone and cartilage structure. This confirms a sustained treatment effect in knee osteoarthritis and supports a disease-modifying effect of XSTEM. Xintela has previously communicated positive interim results up to 18 months after treatment of knee osteoarthritis patients with three dose levels of XSTEM. The highest dose level, which showed the best results after 18 months, has now shown sustained positive treatment effects two years after XSTEM treatment.
XSTEM, which consists of allogeneic (donated) integrin α10β1-selected mesenchymal stem cells, is developed and manufactured by Xintela. [Read more…]
Maryland Governor Wes Moore to Speak at TEDCO’s 2025 Entrepreneur Expo
Join us in College Park on October 21 during the lunch keynote session
COLUMBIA, Md., Sept. 29, 2025 — TEDCO, Maryland’s economic engine for technology companies, announces the attendance of Maryland Governor Wes Moore at the upcoming 2025 Entrepreneur Expo. The premier event will take place at The Hotel at the University of Maryland on October 21, 2025. Gov. Moore will be making a special appearance during the lunch keynote session. [Read more…]
- « Previous Page
- 1
- …
- 10
- 11
- 12
- 13
- 14
- …
- 60
- Next Page »